Swiss Agreement Sees Drug Prices Fall But Access Accelerated
This article was originally published in The Pink Sheet Daily
Executive Summary
The Swiss government and the pharmaceutical industry have reached an agreement that will see prices slashed by 20% over the next three years, but reimbursement decisions to be accelerated by over 300%.